This compound is primarily utilized in the field of biomedical research, particularly in the study of protein degradation and targeted protein knockdown. It serves as a key component in the development of Proteolysis Targeting Chimeras (PROTACs), which are innovative molecules designed to selectively degrade specific proteins within cells. By facilitating the recruitment of E3 ubiquitin ligases to target proteins, it enables their ubiquitination and subsequent degradation by the proteasome. This mechanism is highly valuable in exploring disease-related proteins, especially in cancer research, where it aids in understanding and potentially inhibiting the function of oncogenic proteins. Additionally, it is used in chemical biology to investigate cellular pathways and protein functions, providing insights into therapeutic target discovery and drug development.